Putnam BioRevolution ETF (SYNB) Holdings $28.26 -0.32 (-1.12%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$28.28 +0.02 (+0.07%) As of 06/13/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsRatingsShort InterestBuy This Stock Top 37 SYNB HoldingsRankCompanyCurrent PriceWeightShares Held1TMOThermo Fisher Scientific$402.12-3.2%7.31%8262CTVACorteva$72.36-0.2%5.54%4,3323NVZMYNovozymes A/S$74.89-0.8%5.54%4,1404ABBVAbbVie$190.67-0.9%5.39%1,3405BIOBio-Rad Laboratories$227.43-2.1%5.12%1,0186LLYEli Lilly and Company$818.56+0.8%4.62%2497ASNDAscendis Pharma A/S$170.80-0.1%4.45%1,2678AZNAstraZeneca$74.42-0.8%4.36%2,9439NVDANVIDIA$141.97-2.1%3.80%1,69210CDNSCadence Design Systems$300.00-2.5%3.73%607 Get the Latest News and Ratings for SYNB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. 11REGNRegeneron Pharmaceuticals$529.24+1.4%3.53%28612DHRDanaher$200.51-2.2%3.31%80613DDDuPont de Nemours$66.79-2.4%3.24%2,38214GOOGLAlphabet$174.67-0.6%2.96%90515ZTSZoetis$164.27-2.7%2.65%82116DARDarling Ingredients$35.99+9.1%2.61%3,93017ICLRICON Public$145.66-1.0%2.58%82718Symrise AGN/A2.46%1,03519AVTRAvantor$13.07-3.5%2.32%8,66920BNBrookfield$57.75-2.5%2.06%1,16121ONONON$52.35-6.1%2.06%2,07822Borregaard ASAN/A1.88%5,33023NGVTIngevity$41.88-3.1%1.86%2,73824ARGXargenx$577.89-1.5%1.85%13925TECHBio-Techne$50.52-2.0%1.76%1,69326Net CashN/A1.75%84,69327VRTXVertex Pharmaceuticals$455.45-1.0%1.75%16728PPGPPG Industries$106.25-5.2%1.62%72029BMRNBioMarin Pharmaceutical$56.22-1.9%1.60%1,21630ALNYAlnylam Pharmaceuticals$307.99+1.1%1.22%22431BGBunge Global$81.32+5.6%1.05%64932BIIBBiogen$130.65-1.3%1.01%40633SANBanco Santander$7.97-1.5%0.94%42134LEGNLegend Biotech$36.83-2.8%0.68%94235RCKTRocket Pharmaceuticals$2.93-4.6%0.53%3,40036ABSIAbsci$2.78-2.1%0.47%7,45737CRSPCRISPR Therapeutics$41.36+0.2%0.37%468 Geographic ExposureUnited States85.8%Ireland3.1%France2.8%Germany2.5%Norway2.1%Switzerland1.4%Currency ExposureUSD78.6%EUR5.3%NOK2.1%Sector ExposureHealth Care56.6%Materials24.3%Technology8.6%Consumer Staples3.8%Consumer Discretionary2.3%Financials2.0%Industry ExposureBiotechnology34.1%Chemicals24.3%Health Care Equipment & Supplies17.0%Semiconductors & Semiconductor Equipment4.9%Food Products3.8%Software3.7%Health Care Providers & Services3.1%Life Sciences Tools & Services2.3%Textiles, Apparel & Luxury Goods2.3%Banks2.0%SubIndustry ExposureBiotechnology32.5%Life Sciences Tools & Services19.4%Specialty Chemicals18.0%Fertilizers & Agricultural Chemicals6.3%Semiconductors4.9%Application Software3.7%Health Care Services3.1%Agricultural Products2.8%Footwear2.3%Diversified Banks2.0%Agricultural Products & Services1.0% Related Companies and Tools Related Companies Direxion Daily Travel & Vacation Bull 2X Shares Portfolio Avantis Inflation Focused Equity ETF Portfolio Harbor Transformative Technologies ETF Portfolio Cboe Vest 10 Year Interest Rate Hedge ETF Portfolio NYLI Cleaner Transport ETF Portfolio Invesco MSCI Green Building ETF Portfolio ProShares Ultra Nasdaq Cybersecurity ETF Portfolio Gabelli Automation ETF Portfolio Hypatia Women CEO ETF Portfolio iShares Environmental Infrastructure and Industrials ETF Portfolio This page (NYSEARCA:SYNB) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SYNB Stock Free SYNB Stock Alerts